Published December 21, 2021 | Version v1

Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imaging

  • 1. Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Department of Oncology, Via Mario Negri 2, Milan, Italy.
  • 2. Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Mass Spectrometry Research Center for Health and Environment and Laboratory of Mass Spectrometry, Via Mario Negri 2, Milan, Italy.

Description

Lipids distribution : Quantificazione lipidi nei tessuti

Quantification : Quantificazione di pioglitazone mediante HPLC e MSI nei tumori e nel fegato

Validation HPLC : Validazione metodo dosaggio pioglitazone HPLC

Validation MSI : Validazione metodo dosaggio pioglitazone MSI

Notes

This work was supported by Fondazione AIRC per la Ricerca sul Cancro (AIRC IG 23059 to M.D). The mass spectrometry imaging activities of the present study are part of a research project that was funded by a generous donation of the Paguni Lugli family in memory of Rodolfo Paguni.

Files

Files (164.4 kB)

Name Size
md5:295033ed6bd4f2a14225f414bd9925ab
34.3 kB Download
md5:e45b7f4e8ab93e173b6e38acf83fd18f
42.0 kB Download
md5:af2157e67162ec19faf91bceb652521b
43.0 kB Download
md5:f94f71b6b1959e94f92adda046596faf
45.1 kB Download

Additional details

Related works

Is cited by
Journal article: 10.1016/j.talanta.2021.122918 (DOI)